"Real world" eligibility for aducanumab

被引：28
|
作者：
Canevelli, Marco [1 ,2 ]
Rossi, Paolo Dionigi [3 ]
Astrone, Paolo [4 ]
Consorti, Ernesto [5 ]
Vanacore, Nicola [2 ]
Cesari, Matteo [6 ,7 ]
机构：
[1] Sapienza Univ, Dept Human Neurosci, Viale Univ 30, I-00185 Rome, Italy
[2] Natl Inst Hlth, Natl Ctr Dis Prevent & Hlth Promot, Rome, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Geriatr Unit, Milan, Italy
[4] Azienda Socio Sanit Terr ASST Lodi, Subacute Care Unit, Lodi, Italy
[5] Univ Milan, Geriatr & Gerontol, Milan, Italy
[6] IRCCS Ist Clin Sci Maugeri, Geriatr Unit, Milan, Italy
[7] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2021年 / 69卷 / 10期
关键词：
D O I：
10.1111/jgs.17390
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：2995 / 2998
页数：4
相关论文
共 50 条
  • [31] Real-world patient eligibility for lurbinectedin/doxorubicin in small cell lung cancer
    Rittberg, R.
    Leung, B.
    Al-Hashami, Z.
    Ho, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S101 - S102
  • [32] Real-World Utilization of Corticosteroids in Severe Alcoholic Hepatitis: Eligibility, Response, and Outcomes
    Singeap, Ana-Maria
    Minea, Horia
    Petrea, Oana
    Robea, Madalina-Andreea
    Balmus, Ioana-Miruna
    Duta, Raluca
    Ilie, Ovidiu-Dumitru
    Cimpoesu, Carmen Diana
    Stanciu, Carol
    Trifan, Anca
    MEDICINA-LITHUANIA, 2024, 60 (02):
  • [33] MAPPING REAL-WORLD PSORIATIC ARTHRITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA
    Arendse, Regan
    Haaland, Derek
    Fortin, Isabelle
    Rahman, Proton
    Rampakakis, Emmanouil
    Asin-Milan, Odalis
    Rachich, Meagan
    Nantel, Francois
    Lehman, Allen J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 25 - 26
  • [34] Real-World Application of Anti-β-Amyloid Monoclonal Antibodies Untangling Eligibility
    Howe, Matthew D.
    Rabinovici, Gil D.
    Salloway, Stephen P.
    NEUROLOGY, 2023, 101 (19) : 811 - 812
  • [35] Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study
    Albers, Frank C.
    Muellerova, Hana
    Gunsoy, Necdet B.
    Shin, Ji-Yeon
    Nelsen, Linda M.
    Bradford, Eric S.
    Cockle, Sarah M.
    Suruki, Robert Y.
    JOURNAL OF ASTHMA, 2018, 55 (02) : 152 - 160
  • [36] MAPPING REAL-WORLD RHEUMATOID ARTHRITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA
    Keystone, Edward
    Olszynski, Wojciech
    Bessette, Louis
    Rahman, Proton
    Rampakakis, Emmanouil
    Lehman, Allen J.
    Asin-Milan, Odalis
    Nantel, Francois
    Rachich, Meagan
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 26 - 26
  • [37] Real-world eligibility for vericiguat according to trial, guideline, and labelling eligibility criteria: data from the Swedish Heart Failure Registry
    Nguyen, V. N.
    Lindberg, F.
    Dahlstrom, U.
    Lund, L. H.
    Savarese, G.
    EUROPEAN HEART JOURNAL, 2022, 43 : 963 - 963
  • [38] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, L.
    Gaudio, C.
    Cicogna, F.
    Tota, C.
    Petronilli, V
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5690 - 5700
  • [39] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, L.
    Cicogna, F.
    Tota, C.
    Petronilli, V.
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 42 - 43
  • [40] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, Luca
    Ferrari, Ilaria
    Gaudio, Carlo
    Cicogna, Francesco
    Tota, Claudia
    Petronilli, Valentina
    Mennuni, Silvia
    De Ruvo, Ermenegildo
    Calo, Leonardo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
12345